Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DuPont de Nemours, Inc.DD · Entity 3297 | Director | May 21, 2026 | May 28, 2026 |
| KEYCORP /NEW/KEY · Entity 3220 | Chief Information Officer | February 16, 2026 | February 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DuPont de Nemours, Inc.
Report date May 21, 2026 · Filed May 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,780.6788 |
Reported balance
After 2026-05-21 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-21 · Grant · Acquired 4,030 · Balance 23,780.6788 F1: Includes acquisition of shares pursuant to dividend reinvestment. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes acquisition of shares pursuant to dividend reinvestment.
KEYCORP /NEW/
Report date February 16, 2026 · Filed February 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 60,329 |
Reported balance
After 2026-02-17 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2026-02-17 · Exercise / conversion · Acquired 27,806 · Balance 60,329 F1: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting. |
| Common SharesSEC Table I · non-derivative | Direct | 51,915 |
Reported balance
After 2026-02-17 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2026-02-17 · Tax withholding · Disposed 8,413 · Balance 51,915 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 20,737 |
Reported balance
After 2026-02-16 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-02-16 · Grant · Acquired 20,737 · Balance 20,737 F1: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting. F2: These restricted stock units, granted on February 16, 2026, vest in four equal annual installments beginning on February 17, 2027. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-02-17 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-02-17 · Exercise / conversion · Disposed 5,360 · Balance 0 F1: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting. F4: These restricted stock units, granted on February 14, 2022, vested in four equal annual installments ending on February 17, 2026. F5: Includes approximately 245 dividend-equivalent restricted stock units accrued between March and December 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 6,955 |
Reported balance
After 2026-02-17 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-02-17 · Exercise / conversion · Disposed 6,955 · Balance 6,955 F1: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting. F6: These restricted stock units, granted on February 17, 2023, vest in four equal annual installments beginning on February 17, 2024. F7: Includes approximately 636 dividend-equivalent restricted stock units accrued between March and December 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 17,671 |
Reported balance
After 2026-02-17 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-02-17 · Exercise / conversion · Disposed 8,837 · Balance 17,671 F1: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting. F8: These restricted stock units, granted on February 16, 2024, vest in four equal annual installments beginning on February 17, 2025. F9: Includes approximately 1,212 dividend-equivalent restricted stock units accrued between March and December 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 19,958 |
Reported balance
After 2026-02-17 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-02-17 · Exercise / conversion · Disposed 6,653 · Balance 19,958 F1: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting. F10: These restricted stock units, granted on February 17, 2025, vest in four equal annual installments beginning on February 17, 2026. F11: Includes approximately 1,217 dividend-equivalent restricted stock units accrued between March and December 2025. |
| Option to BuySEC Table II · derivative / convertible security · Conversion / exercise price $23.87 · Expires 0036-02-16 | Direct | 22,692 |
Reported balance
After 2026-02-16 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-02-16 · Grant · Acquired 22,692 · Balance 22,692 F3: The option to buy, granted on February 16, 2026, vests in four equal annual installments beginning on February 17, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents the right to receive one KeyCorp common share at vesting.
F2: These restricted stock units, granted on February 16, 2026, vest in four equal annual installments beginning on February 17, 2027.
F3: The option to buy, granted on February 16, 2026, vests in four equal annual installments beginning on February 17, 2027.
F4: These restricted stock units, granted on February 14, 2022, vested in four equal annual installments ending on February 17, 2026.
F5: Includes approximately 245 dividend-equivalent restricted stock units accrued between March and December 2025.
F6: These restricted stock units, granted on February 17, 2023, vest in four equal annual installments beginning on February 17, 2024.
F7: Includes approximately 636 dividend-equivalent restricted stock units accrued between March and December 2025.
F8: These restricted stock units, granted on February 16, 2024, vest in four equal annual installments beginning on February 17, 2025.
F9: Includes approximately 1,212 dividend-equivalent restricted stock units accrued between March and December 2025.
F10: These restricted stock units, granted on February 17, 2025, vest in four equal annual installments beginning on February 17, 2026.
F11: Includes approximately 1,217 dividend-equivalent restricted stock units accrued between March and December 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 10, 2016 Filed Nov 14, 2016 22:55 UTC | KEYCORP /NEW/ KEY · Entity 3220 | SaleCommon Shares | 9,457 | $15.64 | $147,907.48 |
DisclosureSEC source: 0001294671-16-000203 · edgar.xml · nonDerivative · entry 1 Brady Amy G. · CIK 0001562311 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,827 F1 · balance_after: Includes approximately 19 common shares accrued through dividend reinvestment in March 2016 and approximately 477 common shares acquired under the KeyCorp Amended and Restated Discount Stock Purchase Plan between March 2016 and October 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.